<DOC>
	<DOCNO>NCT02960061</DOCNO>
	<brief_summary>The investigator intend conduct randomize control study find combine HIPEC ( hyperthermic intraperitoneal perfusion chemotherapy ) post-neoadjuvant chemotherapy D2 resection could improve survival patient advance gastric cancer , compare traditional approach D2 resection neoadjuvant chemotherapy .</brief_summary>
	<brief_title>Perioperative Chemotherapy Combined With HIPEC High-risk Advanced Gastric Cancer</brief_title>
	<detailed_description>Gastric cancer , second common malignant tumor china , mark poor prognosis high recurrent rate . Although R0 resection could achieve advanced gastric cancer ( AGC ) patient without metastasis , age-standardized 5-years survival rate 27.4 % . Peritoneal metastasis account 50 % recurrent case remain fatal recurrence pattern . Hyperthermic intraperitoneal perfusion chemotherapy ( HIPEC ) , prove one efficient approach peritoneal carcinomatosis gastric cancer recommend guideline gastric cancer publish health committee china . However , role prophylactic treatment curative never determine . HIPEC work deliver heat cytotoxic drug cancer cell effective tumor small size . As present study suggest Peritoneal metastasis relate lymph node dissection surgery open lymphatic channel spread viable cancer cell peritoneal cavity , HIPEC might reasonable approach destroy remain cancer cell curative surgery . Thus research aim explore efficacy safety combine HIPEC ( hyperthermic intraperitoneal perfusion chemotherapy ) post-neoadjuvant chemotherapy D2 resection .</detailed_description>
	<mesh_term>Stomach Neoplasms</mesh_term>
	<criteria>1 . First diagnose gastric cancer pathological examination ; 2 . No previous chemotherapy radiotherapy ; 3 . T stage:34 , N stage : 13 , M stage : 0 , assess CT ultrasound endoscope ; 4 . Eastern Cooperative Oncology Group performance status ( ECOG PS ) : 01 ; 5 . Informed consent sign ; 1 . Other malignancy within 5 year . 2 . Peritoneal metastasis detect surgery . 3 . Pregnant lactating woman ; 4 . Patients condition require emergency surgery ; 5 . Tumor progress neoadjuvant chemotherapy 6 . Severe , uncontrolled physical metal disease . 7 . Poor compliance . 8 . Uncontrolled infection</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Intraperitoneal chemotherapy</keyword>
	<keyword>gastric cancer</keyword>
	<keyword>Neo-adjuvant chemotherapy</keyword>
</DOC>